Oncology Services
Various Cancers
PreclinicalActive
Key Facts
About Transcure Bioservices
Transcure Bioservices is a Paris-based preclinical CRO that provides specialized research services using proprietary humanized mouse models. The company focuses on accelerating drug discovery in oncology, inflammation, and infectious diseases by offering more predictive preclinical data through models that incorporate human biological systems. With approximately 70 employees and over 12 years of collective experience, Transcure positions itself as a flexible and transparent partner for biopharma companies, emphasizing tailored study designs and a collaborative approach. It is a private, likely revenue-generating services business, not a therapeutic developer.
View full company profileTherapeutic Areas
Other Various Cancers Drugs
| Drug | Company | Phase |
|---|---|---|
| Oncology/Immuno-oncology Portfolio | MSD | Phase III/Commercial |
| Bevacizumab Biosimilar | Dr. Reddy's Laboratories | Approved |
| LADR Platform | LadRx | Preclinical |
| NK Cell Stimulation (via JadiCell) | Therapeutic Solutions International | Preclinical |
| Zip-Code Library for Oncology | Kodikaz Therapeutic Solutions | Pre-clinical |
| Proprietary RLT Pipeline | Affibody | Not Specified (Preclinical-Phase 2) |
| Preclinical ASO Portfolio | Isarna Therapeutics | Preclinical |
| SPACE-GM Microenvironment Analysis | Enable Medicine | Research |
| Oncology Program(s) | CIS Pharma | Pre-clinical |
| Max Access Solutions (with The Max Foundation) | Tanner Pharma Group | N/A (Donation/Distribution Program) |
| CPA Platform in Oncology | InnoSIGN | Development |
| SBX 2021 | Stramsen Biotech | Early-stage Clinical |